This information is for research and educational purposes only. No medical recommendations. Products are not approved for human use. For health questions, consult a doctor.

Lexicon

Muscle & performance

Cardarine (GW-501516)

Not a SARM but a PPAR-delta agonist with an endurance profile, famous from exercise-mimetic research and infamous for the rodent cancer data.

2 min read 1 sources Titration Updated May 2026
Class
PPAR-delta agonist (not a SARM)
Use
Oral (daily)
Half-life
approx. 16 to 24 hours
WADA
Banned (hormone and metabolic modulators)

Getting started

Reported dosing (research community)

Per-day figures. Cardarine is not a SARM but a PPAR-delta agonist. Note the honest cancer context further down.

Members only

Dosing recommendations are visible to logged-in members only. Logging in is free.

Log in / sign up

What is Cardarine?

Cardarine, also GW-501516, is often mentioned in the same breath as SARMs but is not one. It is an agonist at the PPAR-delta receptor, a switch in energy metabolism. It was originally developed by GlaxoSmithKline for metabolic disease.

In the community Cardarine is known mainly for its endurance and fat-burning profile. Equally important is an honest read of the animal data, see below.

How it works

Through the PPAR-delta receptor Cardarine switches on programs in muscle cells tied to fat burning and oxidative metabolism. In animal models this shifted energy use toward fat and increased endurance performance.

Cardarine does not act on the androgen receptor, so it does not suppress the testosterone axis. It is hormonally neutral, which fundamentally separates it from the SARMs.

How to take it

Oral, usually once daily.

  • One dose per day is generally enough, some split because of the half-life.
  • Often taken before training.
  • With some water, with or without food.

Dosing

Members only

Dosing recommendations are visible to logged-in members only. Logging in is free.

Log in / sign up

What the research shows

The best-known study (Narkar, 2008) showed in mice that GW1516 together with training markedly increased the number of oxidative muscle fibers and endurance performance, a classic exercise-mimetic result.

The other side: GlaxoSmithKline stopped development after long-term animal studies at high doses showed increased tumors in several organs. That is the central reason Cardarine never reached approval. Human long-term safety data are missing. Anyone using Cardarine should know these animal data and not talk them away.

Side effects

  • Central point: increased tumor rate in long-term animal studies at high doses, the reason for the development stop.
  • Short term, users report few acute effects, which is exactly what hides the real risk.
  • No solid long-term human safety data.

Practice

  • The animal tumor data are real, take them seriously rather than ignoring them.
  • If at all, then low and not over long periods.
  • Banned and detectable in official competition.

Storage

Store dry, cool and protected from light, out of reach of children. Keep the original container closed and mind the expiry date.

Evidence

Sources

  1. 1 AMPK and PPAR-delta agonists as exercise mimetics (GW1516 in a mouse model). Narkar et al., Cell, 2008

Keep reading

More in the lexicon

In the shop

Cardarine (GW-501516) in the catalog

Sizes, prices and availability for research use. Straight from the lexicon to the product page.

View in shop